Using non-invasive nerve stimulation to help infants with opioid withdrawal
Delivering Transcutaneous Auricular Neurostimulation as an Adjunct Treatment for Neonatal Opioid Withdrawal Syndrome
['FUNDING_SBIR_2'] · SPARK BIOMEDICAL INC · NIH-10491343
This study is looking at a gentle treatment called transcutaneous auricular neurostimulation to help babies who are going through withdrawal after being exposed to opioids before birth, with the hope of making them feel better without relying on more medications.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SPARK BIOMEDICAL INC (nih funded) |
| Locations | 1 site (FRIENDSWOOD, UNITED STATES) |
| Trial ID | NIH-10491343 on ClinicalTrials.gov |
What this research studies
This research investigates the use of transcutaneous auricular neurostimulation as an additional treatment for Neonatal Opioid Withdrawal Syndrome (NOWS) in infants. NOWS occurs when babies experience withdrawal symptoms after being exposed to opioids in the womb. The study aims to evaluate how this non-invasive technique can help alleviate the symptoms of withdrawal, potentially reducing the need for traditional opioid treatments. By focusing on a safer, alternative approach, the research seeks to improve the overall care and outcomes for affected infants.
Who could benefit from this research
Good fit: Ideal candidates for this research are newborns diagnosed with Neonatal Opioid Withdrawal Syndrome who have been exposed to opioids during pregnancy.
Not a fit: Patients who are not newborns or those who have not been exposed to opioids in utero may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a safer treatment option for infants suffering from opioid withdrawal, reducing their reliance on harmful medications.
How similar studies have performed: Previous studies have shown promise in using non-invasive techniques for managing withdrawal symptoms, suggesting that this approach could be effective.
Where this research is happening
FRIENDSWOOD, UNITED STATES
- SPARK BIOMEDICAL INC — FRIENDSWOOD, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KHODAPARAST, NAVID — SPARK BIOMEDICAL INC
- Study coordinator: KHODAPARAST, NAVID
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.